Statute Details
- Title: Foreign Employee Dormitories (Prescribed Associates) Regulations 2022
- Act Code: FEDA2015-S706-2022
- Type: Subsidiary legislation (SL)
- Authorising Act: Foreign Employee Dormitories Act 2015
- Enacting authority: Minister for Manpower (powers under section 34 of the Foreign Employee Dormitories Act 2015)
- Commencement: 31 August 2022
- Legislation number: SL 706/2022 (dated 31 Aug 2022)
- Status: Current version as at 27 March 2026
- Key provisions (in the extract): Regulations 1 to 3
- Core legal function: Prescribes who counts as an “associate” of an applicant (individual or body corporate) for purposes of section 9(4) of the Act
What Is This Legislation About?
The Foreign Employee Dormitories (Prescribed Associates) Regulations 2022 (“Prescribed Associates Regulations”) are subsidiary legislation made under the Foreign Employee Dormitories Act 2015 (“FEDA”). In plain terms, the Regulations help define the boundaries of who is considered an “associate” of an applicant when the Ministry of Manpower (MOM) assesses applications under the FEDA framework.
The practical importance of this kind of definition is that “associates” often determine whether certain persons or entities are treated as effectively connected to the applicant. That, in turn, can affect eligibility, compliance expectations, and the scope of information or scrutiny required in dormitory-related applications. Here, the Regulations specifically address “prescribed associates” for the purposes of section 9(4) of the Act.
Although the Regulations are short, they are highly technical. They translate relationship and control concepts—such as family ties, partnership arrangements, corporate control, and significant shareholding—into legally workable tests. For practitioners, the Regulations are best understood as a “mapping” tool: they tell you which relationships will be treated as associates, even if the applicant tries to characterise them differently.
What Are the Key Provisions?
Regulation 1 (Citation and commencement) is straightforward. It provides the formal name of the Regulations and states that they come into operation on 31 August 2022. This matters for determining which version applies to applications and events occurring on or after commencement.
Regulation 2 (Prescribed associates of an applicant who is an individual) is the first substantive provision. It addresses the situation where the applicant (“A”) is an individual and the question becomes: who is an “associate” of A for the purposes of section 9(4) of the Act?
Regulation 2(1) sets out two main categories:
- Associates who are individuals (B): B is an associate of A if B is:
- a relative or spouse of a relative of A or A’s spouse;
- in partnership with A;
- the relative of a person with whom B is in partnership, or the relative of a person with whom A is in partnership; or
- has control over A.
- Associates who are entities (C): an entity is an associate of A if A is or was a company director, managing director, chief executive officer, manager, partner, or sole proprietor of C.
This structure is significant. It captures both (i) personal relationships and partnership links, and (ii) corporate/operational links through roles held by the individual applicant. In other words, the Regulations do not limit “associate” to family members; they also extend to business structures connected to the applicant through past or current management positions.
Regulation 2(2) then provides interpretive rules that expand and clarify the tests:
- “Relative” takes its meaning from section 2(1) of the Act.
- Spouse includes former spouse, which prevents applicants from avoiding associate status by relying on relationship termination.
- Control test (for paragraph 2(1)(a)(iv)): B is taken to have control over A if A is accustomed to act in accordance with B’s directions or instructions. This is a “de facto control” concept and is broader than formal legal control.
- “Entity” definition: includes sole proprietorships, partnerships, and body corporates, with or without limited liability. This ensures that “associate” coverage is not limited to incorporated companies.
Regulation 3 (Prescribed associates of an applicant which is a body corporate) addresses the corporate applicant scenario. Here, the applicant (“D”) is a body corporate, and the Regulations prescribe associates for section 9(4) purposes.
Regulation 3(1) again divides associates into two categories: associates who are individuals (E) and associates who are other body corporates (F).
For an individual E to be an associate of D, Regulation 3(1)(a) provides three alternative triggers:
- E has control over D; or E and persons who are E’s associates together have control over D;
- E has a significant interest in D; or E and E’s associates together have a significant interest in D;
- E is or was a company director, managing director, chief executive officer, or manager of D or of D’s subsidiary or holding company.
For a body corporate F to be an associate of D, Regulation 3(1)(b) mirrors the same structure:
- F has control over D (or together with F’s associates);
- F has a significant interest in D (or together with F’s associates);
- F is a subsidiary of D or the holding company of D.
Practitioners should note the “together” language. It allows aggregation of control or significant interest where multiple persons/entities are associates of E or F. This is a common regulatory technique to prevent circumvention by splitting interests across related parties.
Regulation 3(2) imports corporate structure definitions by reference to the Companies Act 1967 for “subsidiary” and “holding company”. This reduces ambiguity and ensures consistency with mainstream corporate law concepts.
Control and significant interest tests are further elaborated in Regulations 3(3) and 3(4).
Regulation 3(3) (control) provides that E or F is taken to have control of D if any of these apply:
- De facto direction: the directors of D (or directors of another body corporate which has control of D) are accustomed to act in accordance with E’s or F’s directions or instructions.
- Board appointment/removal rights: E or F holds the right (directly or indirectly) to appoint or remove directors (or equivalent persons) of D who hold a majority of voting rights at directors’ meetings on all or substantially all matters.
- Voting power threshold: E or F is entitled to exercise, or control the exercise of, 25% or more of the voting power at any general meeting of D (or of another body corporate which has control of D).
Regulation 3(3) also provides that where two or more persons together satisfy the relevant sub-paragraphs, they are taken to have control of D. This again supports an anti-avoidance approach.
Regulation 3(4) (significant interest) sets out a threshold-based test. E or F is taken to have a significant interest in D if:
- Where D has share capital:
- E or F has an interest in more than 25% of the shares in D; or
- E or F has an interest in one or more voting shares where the total votes attached to those shares are more than 25% of the total voting power in D.
- Where D does not have share capital: E or F holds, directly or indirectly, a right to share in more than 25% of the capital or more than 25% of the profits of D.
As with control, Regulation 3(4) includes aggregation where two or more persons together satisfy the relevant thresholds.
How Is This Legislation Structured?
The Regulations are structured as a short instrument with three operative provisions:
- Regulation 1: Citation and commencement.
- Regulation 2: Prescribed associates where the applicant is an individual (including relatives, spouses/former spouses, partnership links, de facto control, and entities connected through the individual’s roles).
- Regulation 3: Prescribed associates where the applicant is a body corporate (including control and significant interest tests, plus corporate roles and subsidiary/holding relationships).
There are no additional Parts or schedules in the extract provided. The Regulations function primarily as definitional and threshold-setting rules tied to section 9(4) of the FEDA.
Who Does This Legislation Apply To?
These Regulations apply to applications under the Foreign Employee Dormitories Act 2015 where the applicant is assessed under section 9(4). The Regulations do not operate in isolation; they define “prescribed associates” that MOM will treat as connected to the applicant for the relevant statutory purpose.
Accordingly, the Regulations apply to:
- Individual applicants (Regulation 2), and the individuals/entities linked to them through family, partnership, de facto control, or management/ownership roles; and
- Corporate applicants (Regulation 3), and the individuals/entities linked through control, significant interest, management roles, and subsidiary/holding relationships.
Why Is This Legislation Important?
For practitioners, the key value of the Prescribed Associates Regulations is that they provide clear legal tests for determining who counts as an associate. In dormitory-related regulatory processes, “associate” status can influence how MOM views the applicant’s governance, influence, and potential compliance risks. The Regulations therefore affect both substantive eligibility and practical disclosure strategy.
The Regulations are also important because they include anti-avoidance mechanisms through aggregation (“together”) and de facto control concepts (“accustomed to act in accordance with directions or instructions”). This means that formal corporate charts or contractual arrangements may not be sufficient to avoid associate classification if the underlying reality shows influence or control.
Finally, the thresholds—particularly the 25% voting power and more than 25% significant interest thresholds—are likely to be operationally decisive. Lawyers advising applicants should map ownership, voting rights, board appointment/removal rights, and management relationships against these tests to ensure that all prescribed associates are identified and addressed appropriately.
Related Legislation
- Foreign Employee Dormitories Act 2015
- Companies Act 1967 (definitions of “subsidiary” and “holding company”)
Source Documents
This article provides an overview of the Foreign Employee Dormitories (Prescribed Associates) Regulations 2022 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.